Financials
- Market Capitalization 684.93 M
- Employee 73
- Founded 2005
- CEO Jason Okazaki
- Website www.assemblybio.com
- Headquarter Delaware, United States
- FIGI BBG000R62Q06
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2705 | TECX Tectonic Therapeutic, Inc. - Common Stock | 35.84 USD | -2.34% | -3.84% | +20.15% | +108.98% | 700.65 M USD | ||
| 2715 | ZVRA Zevra Therapeutics, Inc. - Common Stock | 11.64 USD | -1.77% | -2.18% | +19.75% | +9.40% | 691.23 M USD | ||
| 2743 | SGMT Sagimet Biosciences Inc. - Series A Common Stock | 10.66 USD | -0.84% | +3.70% | +46.23% | +41.01% | 662.61 M USD | ||
| 2744 | PRME Prime Medicine, Inc. - Common Stock | 3.65 USD | +0.27% | +7.67% | +18.89% | +5.49% | 662.03 M USD |
Frequently asked questions about Assembly Biosciences, Inc
What is the Assembly Biosciences, Inc stock price today?
The current price of Assembly Biosciences, Inc (ASMB) is 33.64. Over the past 24 hours, the stock has changed by -3.33%. Follow the ASMB chart for real-time price dynamics.
What is the stock ticker of Assembly Biosciences, Inc?
Assembly Biosciences, Inc trades under the ticker ASMB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Assembly Biosciences, Inc stock going up?
ASMB has changed by -1.78% over the last week, +30.64% over the last month, and +14.32% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Assembly Biosciences, Inc?
Assembly Biosciences, Inc currently has a market capitalization of 684.93 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Assembly Biosciences, Inc earnings last quarter?
Last quarter, Assembly Biosciences, Inc reported earnings of -0.2 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Assembly Biosciences, Inc revenue for the last quarter?
Assembly Biosciences, Inc reported quarterly revenue of 13.37 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Assembly Biosciences, Inc net income for the last quarter?
Assembly Biosciences, Inc reported net income of -3.86 M for the last quarter. The previous quarter showed -9.08 M, which means net income changed by +57.52%.
How many employees does Assembly Biosciences, Inc have?
As of the latest available data, Assembly Biosciences, Inc has 73 employees. Workforce size can provide additional context about the company's scale and operations.
What is Assembly Biosciences, Inc EBITDA?
Assembly Biosciences, Inc EBITDA is -6.32 M, and its EBITDA margin is -47.29%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Assembly Biosciences, Inc stock?
You can buy Assembly Biosciences, Inc (ASMB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Assembly Biosciences, Inc stock?
Investing in Assembly Biosciences, Inc requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ASMB chart and related analysis on metatrader.com as part of your research.